Details of the Drug Reposition

General Information of This Drug (ID: DM1J0YB)

• Drug Name: SLX-2101 (DM1J0YB)

Information on Drug Reposition of This Drug

3 Discontinued in Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Hypertension	DISLL965	BA00-BA04	Discontinued in Phase 2	[1]
Raynaud disease	DIS86ETN	BD42.0	Discontinued in Phase 2	[1]
Erectile dysfunction	DISD8MTH	HA01.1	Discontinued in Phase 2	[1]

References

• [1] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022583)